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Creation of Polyacrylamide Substrates and Cell Plating 
Traction Force Microscopy 
Data Analysis 
1. A polyacrylamide gel (PAG) solution is mixed with fluorescent nanobeads in a microcentrifuge tube. 
2. PAG is pipetted into a 35 mm glass-bottom MatTek dish. 
3. PAG is allowed to polymerize and is then coated with collagen. 
4. U251 glioma cells suspended in media (pink) are allowed to adhere to collagen-coated PAG substrate. 
1. A cell is imaged with transmitted light. The cell is exerting a traction force on the substrate. 
2. Nanobeads in the substrate directly under cell are imaged. The beads fluoresce under yellow light. 
3. The cell is chemically detached from the substrate with Trypsin, a compound that targets integrins. 
4. The nanobeads are imaged again with no force being exerted on the substrate. 
 
If a drug is to be used for a data set, the desired concentration of the drug is added to the cell media in the dish 
30 minutes prior to imaging. 
 
Glioblastoma multiforme, also known as Grade IV Glioma, is a malignant brain tumor in humans that is 
characterized by highly migratory and invasive cells that spread throughout the brain. Standard treatment of 
many invasive cancers employs the use of microtubule-targeting agents, which disrupt microtubule dynamics 
inside cells. Microtubules play a role in regulating the traction forces necessary for cell migration, but the 
mechanism by which they do this is not yet known. If more is learned about microtubules’ role in cell migration, 
there will be potential for improvements on current treatment methods. Here we show that vinblastine, a drug 
that promotes microtubule depolymerization, increases the traction forces exerted by glioma cells on the 
extracellular environment in vitro. We also show that cells treated with blebbistatin (a drug that decreases cell 
traction force by inhibiting myosin II motor proteins) experience a recovery of traction force when treated with 
vinblastine. Based on these results, we conclude that increased depolymerization of microtubules in glioma 
cells causes an increase in cell traction force by increasing myosin II activity. 
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Background 
5 uM Blebbistatin 30 nM Vinblastine Both Drugs 
Increasing Dose of Vinblastine 
Results 
Cells were treated with 3, 10, or 30 nM 
vinblastine. Cells treated with higher 
concentrations of vinblastine  experienced a 
greater rise in traction force. These averages 
include only those cells which were fully 
adhered to the substrate.  
Additionally, it was observed that in dishes 
treated with higher concentrations of 
vinblastine, a greater fraction of cells were 
rounded and barely adherent to the substrate. 
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Strain Energy of Cells Treated with Vinblastine 
 23.1 ± 4.0 
 4.47 ± 0.86 
 10.1 ± 2.1 
 4.42 ± 1.5 
  n=112                      n=20              n=65             n=65 
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Vinblastine Blebbistatin Multidrug 
 4.47 ± 0.86 
 2.42 ± 0.84 
 23.1 ± 4.0 
 4.43 ± 1.6 
    n=112                       n=30               n=65                n=28 
Multidrug – Vinblastine and Blebbistatin 
Cells were treated with 5 uM blebbistatin, 30 
nM vinblastine, or a combination of both drugs. 
The resulting traction force data shows that 
cells treated with both drugs experience a 
recovery of traction force when compared to 
cells treated with blebbistatin only. 
Because blebbistatin decreases traction force 
by inhibiting myosin II motors, this data 
suggests that the increase in traction force of 
vinblastine-treated cells can be explained by 
increased myosin II activity. 
It is hypothesized that the mechanism by which cells exert forces on their 
surroundings is a motor-clutch system.3 In this system, actin fibers 
polymerize at the leading edge of the cell and bond to integrins, or 
“clutches,” which the cell uses adhere itself to its substrate.  Myosin II 
motors pull the actin fibers retrogradely, and thus the cell exerts a 
traction force through the clutches. 
In glioma cells, as well as all animal cells, microtubules inside the cells are continually polymerizing and 
depolymerizing, extending from and retreating back to the centrosome. This is known as dynamic instability. It 
has been observed that dynamic instability plays a role in regulating cell traction, as well as movement.1 
Vinblastine is a microtubule-targeting agent that promotes microtubule depolymerization, which causes 
microtubules to extend toward the edges of the cell but never retreat, disrupting dynamic instability.  
Microtubules in a cell2 
Motor-Clutch Model3 
Since the disruption of dynamic instability affects cell traction, it can be concluded that microtubules have an 
influence on the function of the motor-clutch system. Many tools and methods can be used to investigate the 
details of this influence, one of which is the drug blebbistatin. Blebbistatin decreases myosin motor activity, so 
it can be used in conjunction with other drugs, such as vinblastine, to gain insight into the influence 
microtubules have on the motor-clutch system.   
Glioma cell with nanobeads (green) and superimposed beads in the relaxed substrate. 
The results of the experiments suggest that increased depolymerization of microtubules in glioma cells 
increases myosin II activity. When cells are treated with vinblastine, which promotes depolymerization, an 
increase in cell traction is observed. When cells are treated with blebbistatin and vinblastine, they experience a 
recovery of traction force when compared to cells treated with blebbistatin only. Additionally, cells treated with 
vinblastine exhibit smaller surface areas than cells treated with both blebbistatin and vinblastine.  These results 
are all supportive of the hypothesis that microtubules influence myosin motor activity, and that increased 
depolymerization of microtubules increases motor activity. 
The image of the cell, the image of the beads with an exerted force, and the image of the beads with the cell 
detached are combined into a stack.  A MATLAB script is used to match and align the bead images. Because the 
traction force of the cell causes the beads to move between the two images, only those beads further from the 
cell are used in the alignment. The distance the beads around the cell move is now apparent, and because the 
Young’s modulus of the substrate is known, another MATLAB script is then used to determine the force that was 
being exerted by the cell. 
Multidrug Cell Areas 
Cells were treated with 5 uM blebbistatin, 30 
nM vinblastine, or a combination of both drugs. 
A large image of a PAG substrate with cells was 
taken, after which a MATLAB script was used to 
determine the areas of each cell.  
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  n=58                         n=67                    n=155                n=218 
1783 ± 67 
1205 ± 61 
848 ± 35 
1067 ± 31 
Because myosin pulls actin and clutches toward the center of the cell, it can be predicted that cells with greater 
myosin activity will exhibit a smaller surface area when viewed on a flat substrate. The results of this 
experiment show that cells treated with vinblastine exhibit a smaller surface area than cells treated with both 
drugs. This data supports the hypothesis that increased depolymerization of microtubules via vinblastine 
results in greater myosin activity. 
It is evident that cells treated with vinblastine have a smaller surface area than cells treated with blebbistatin or both drugs 
A glioma cell on a PAG substrate. Fluorescent nanobeads beneath the cell 
